These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16632694)

  • 21. Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location.
    Francica G; Petrolati A; Di Stasio E; Pacella S; Stasi R; Pacella CM
    AJR Am J Roentgenol; 2012 Dec; 199(6):1393-401. PubMed ID: 23169736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy.
    Choi D; Lim HK; Kim MJ; Lee SH; Kim SH; Lee WJ; Lim JH; Joh JW; Kim YI
    Radiology; 2004 Jan; 230(1):135-41. PubMed ID: 14631050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effectiveness of radiofrequency ablation for solitary small hepatocellular carcinoma: a retrospective analysis of 363 patients.
    Francica G; Saviano A; De Sio I; De Matthaeis N; Brunello F; Cantamessa A; Giorgio A; Scognamiglio U; Fornari F; Giangregorio F; Piscaglia F; Gualandi S; Caturelli E; Roselli P; Rapaccini GL; Pompili M
    Dig Liver Dis; 2013 Apr; 45(4):336-41. PubMed ID: 23245589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous radiofrequency ablation of hepatocellular carcinoma: effect of histologic grade on therapeutic results.
    Kim SH; Lim HK; Choi D; Lee WJ; Kim SH; Kim MJ; Kim CK; Jeon YH; Lee JM; Rhim H
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S327-33. PubMed ID: 16632696
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency ablation for the treatment of bone metastases from hepatocellular carcinoma.
    Kashima M; Yamakado K; Takaki H; Kaminou T; Tanigawa N; Nakatsuka A; Takeda K
    AJR Am J Roentgenol; 2010 Feb; 194(2):536-41. PubMed ID: 20093621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.
    Okuwaki Y; Nakazawa T; Kokubu S; Hidaka H; Tanaka Y; Takada J; Watanabe M; Shibuya A; Minamino T; Saigenji K
    Am J Gastroenterol; 2009 Nov; 104(11):2747-53. PubMed ID: 19603009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
    Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
    Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
    Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY
    Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
    Vallone P; Catalano O; Izzo F; Siani A
    Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
    Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.
    Yamakado K; Nakatsuka A; Akeboshi M; Shiraki K; Nakano T; Takeda K
    Oncol Rep; 2004 Jan; 11(1):105-9. PubMed ID: 14654911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
    Fontana RJ; Hamidullah H; Nghiem H; Greenson JK; Hussain H; Marrero J; Rudich S; McClure LA; Arenas J
    Liver Transpl; 2002 Dec; 8(12):1165-74. PubMed ID: 12474157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas larger than 5 cm.
    Takaki H; Yamakado K; Uraki J; Nakatsuka A; Fuke H; Yamamoto N; Shiraki K; Yamada T; Takeda K
    J Vasc Interv Radiol; 2009 Feb; 20(2):217-24. PubMed ID: 19097810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of intraoperative radiofrequency ablation in management of hepatocellular carcinoma.
    Rizk H; Magdy M; Reda M; Alaa T; El-Shafie MM; Ghanem M; Saed T
    J Egypt Soc Parasitol; 2008 Dec; 38(3):715-26. PubMed ID: 19209757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CT-guided radiofrequency ablation after with transarterial chemoembolization in treating unresectable hepatocellular carcinoma with long overall survival improvement.
    Zhao M; Wang JP; Pan CC; Li W; Huang ZL; Zhang L; Fang WJ; Jiang Y; Li XS; Wu PH
    Eur J Radiol; 2012 Oct; 81(10):2717-25. PubMed ID: 22245655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous radiofrequency ablation of liver tumors using multiple saline-perfused electrodes.
    Hänsler J; Frieser M; Tietz V; Uhlke D; Wissniowski T; Bernatik T; Hothorn T; Hahn EG; Strobel D
    J Vasc Interv Radiol; 2007 Mar; 18(3):405-10. PubMed ID: 17377187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.